“Paediatric Inflammatory Multisystem Syndrome”

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.

ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024

What is the News?

According to a study by Lancet, the symptoms of a rare paediatric inflammatory multisystem syndrome(PIMS-TS) associated with SARS-CoV2 are resolved after six months.

About Paediatric Inflammatory Multisystem Syndrome(PIMS-TS):
  • PIMS-TS is also known as a multisystem inflammatory syndrome in children (MIS-C). It is a rare condition associated with SARS-CoV-2 infection that was first defined in April 2020.
  • Caused by: It is not known what triggers the condition. But it is thought to be a rare immune overreaction that occurs in children approximately four to six weeks after mild or asymptomatic SARS-CoV-2 infection.
  • Symptoms: It includes fever, rash, eye infection, and gastrointestinal symptoms (e.g. diarrhoea, stomach ache, nausea). In some rare cases, the condition can lead to multi-organ failure.
  • Diagnosis: Currently, MIS-C is diagnosed based on symptoms together with laboratory tests that look for signs of inflammation in the body.
  • Treatment: Treatments currently include anti-coagulation to curb blood clotting, IV immunoglobulin and anti-inflammatory drugs.
About the Lancet Study:
  • The Lancet study has been conducted on a small group of children affected with PIMS-TS.
  • The study has found that most gastrointestinal, heart and neurological symptoms in children are resolved within six months of the COVID-19 infection.
  • Moreover, the long-term damage to the organs is thought to be a rare occurrence.

Source: Indian Express

Print Friendly and PDF
Blog
Academy
Community